2025年12月3日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏原（NDA）研究小组就蛋膜胶原蛋白肽（egg membrane collagen peptides）作为新型食品的安全性发表科学意见。
经过评估，专家小组得出结论，在提议的使用条件下，蛋膜胶原蛋白肽作为新型食品是安全的。部分原文报道如下：
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced by enzymatic hydrolysis, and it contains 15%–30% collagen peptides. The production process is sufficiently described and does not raise safety concerns. The applicant proposed to market the NF for use in food supplements for adults, excluding pregnant and lactating women, at a maximum daily dose of 500 mg. Taking into account the nature of the NF, the compositional data and information on the production process, the Panel considers that no toxicological studies are required for the NF. The Panel concludes that the NF, egg membrane collagen peptides, is safe under the proposed conditions of use.
